Increasing Access to Innovative Medicines
Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget
Transforming Canadians’ lives
Partnering to champion policies that drive the discovery, development and delivery of transformative medicines and vaccines.
BENEFITS OF INNOVATIVE MEDICINES
Real hope for patients and families
New medicines and vaccines save lives and help make our healthcare system more cost‑effective.
Transformation
Preventing or curing disease means extending lives, relieving suffering and improving people’s quality of life.
Safety
Promoting a robust regulatory protocol means ensuring safe and effective medicines for Canadians.
Sustainability
Supporting sustainable healthcare means we all spend more time enjoying life and being productive.
Industry impact In Canada
Better Health Outcomes
46
Innovative Medicines Canada members
103,000
High-quality jobs
$16 billion
Total yearly economic impact
LATEST RESOURCES
Cost Drivers Report 2024: Analysis of Private Drug Plan Trends in Canada
For the second year in a row,
we saw considerable growth
in the number of claimants
with an 8.5% increase, making
it the main driver of overall
cost. This increase in claimants
was balanced by a low single
digit increase in the cost per
claimants of 2.7%. Read the full report.
LATEST PRESS RELEASES
Press Release March 21, 2025
IMC Calls for Pharmacare Reform to Ensure Access to Innovative Medicines and Protect Personalized Care
Ottawa, March 21, 2025 – With the imminent announcement of a federal election, Canadians have an opportunity to reflect on […]
Press Release February 03, 2025
Innovative Medicines Canada Welcomes Patrick Hupé as Vice President of Government and Stakeholder Relations
Ottawa, February 3, 2025 – Innovative Medicines Canada (IMC) is pleased to welcome Patrick Hupé, M.Sc., MBA, as Vice President […]
Press Release December 16, 2024
Statement from Innovative Medicines Canada on the Release of the 2024 Federal Fall Economic Statement
Ottawa, December 16, 2024 – Following the release of the Fall Economic Statement, Innovative Medicines Canada (IMC) is calling on […]
Press Release December 16, 2024
Innovative Medicines Canada Applauds Premiers’ Agreement at 2024 Council of the Federation Meeting to Accelerate Access to Life-Saving Medications
Toronto, December 16, 2024 – Innovative Medicines Canada (IMC) welcomes the collective agreement amongst Canada’s Premiers to take meaningful action […]
Press Release November 19, 2024
Bristol-Myers Squibb Canada Wins The 2024 Prix Galien Innovative Product Award
CAMZYOS™ RECOGNIZED FOR THE TREATMENT OF obstructive hypertrophic cardiomyopathy Ottawa, November 19, 2024 – Prix Galien Canada is pleased to […]
Press Release November 19, 2024
The Health Research Foundation Announces The 2024 Medal Of Honour And Diversity & Equity in Research Award Winners
DR. MICHAEL HILL WINS THE MEDAL OF HONOUR, DR. SONIA ANAND WINS THE DIVERSITY AND EQUITY IN RESEARCH AWARD Ottawa, […]
Press Release November 15, 2024
Statement from Innovative Medicines Canada on the Committee of Experts to make recommendations on National Pharmacare
We are disappointed to see that, once again, the government has excluded the pharmaceutical industry’s voice from important discussions on […]
Press Release October 15, 2024
Statement from Innovative Medicines Canada on Ontario’s Next Phase of the Life Sciences Strategy
Today’s announcement by the Ontario government of a $146 million investment in the next phase of the Life Sciences Strategy […]
